Immunity to pneumococcal antigens in kidney transplant recipients

Transplantation

Volumn 90, Issue 12, 2010, Pages 1463-1467

  Lindemann, Monika ^a   Heinemann, Falko M ^a   Horn, Peter A ^a   Witzke, Oliver ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Kidney transplantation; Luminex technology; Pneumococcal antigens; Serotype specific antibody response

Indexed keywords

AZATHIOPRINE; BACTERIUM ANTIBODY; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; PREDNISONE; TACROLIMUS;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; GRANULOCYTE; HUMAN; IMMUNIZATION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MONOCYTE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNITY; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES, BACTERIAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 78650831659     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f5d878     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46 (No. RR-8): 1.
2. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epid Bull 2009; 30: 279.
3. Klugman KP, Chien YW, Madhi SA. Pneumococcal pneumonia and influenza: A deadly combination. Vaccine 2009; 27(suppl 3): C9.
4. Butler J. Epidemiology of pneumococcal disease. In: Tuomanen EI, Mitchell TJ, Morrison D, et al, eds. The pneumococcus, vol. 10. Washington, DC, American Society for Microbiology 2004, pp 148-168.
5. Rubins JB, Puri AK, Loch J, et al. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults. J Infect Dis 1998; 178: 431.
6. Robert Koch-Institut. PneumoWeb, 2010.
7. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5: 83.
8. Borgers H, Moens L, Picard C, et al. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay. Clin Immunol 2010; 134: 198.
9. Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008: CD000422.
10. Uddin S, Borrow R, Haeney MR, et al. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity. Vaccine 2006; 24: 5637.
11. Romero-Steiner S, Musher DM, Cetron MS, et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999; 29: 281.
12. Ortqvist A, Henckaerts I, Hedlund J, et al. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly. Vaccine 2007; 25: 2445.
13. Boyle RJ, Le C, Balloch A, et al. The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol 2006; 146: 486.
14. Rytel MW, Dailey MP, Schiffman G, et al. Pneumococcal vaccine immunization of patients with renal impairment. Proc Soc Exp Biol Med 1986; 182: 468.
15. Arnold WC, Steele RW, Rastogi SP, et al. Response to pneumococcal vaccine in renal allograft recipients. Am J Nephrol 1985; 5: 30.
16. Giebink GS, Le CT, Cosio FG, et al. Serum antibody responses of highrisk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae. Rev Infect Dis 1981; 3: S168.
17. Silberman H, Overturf GD, Field RJ, et al. Response of renal allograft recipients to pneumococcal vaccine. Ann Surg 1980; 192: 199.
18. Lindemann M, Witzke O, Lütkes P, et al. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Clin Immunol 2006; 120: 342.
19. Murthy K, Stevens LA, Stark PC, et al. Variation in the serum creatinine assay calibration: A practical application to glomerular filtration rate estimation. Kidney Int 2005; 68: 1884.
20. Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol 1995; 13: 655.
21. Taillardet M, Haffar G, Mondiere P, et al. The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells. Blood 2009; 114: 4432.
22. Budde K, Carpenter CB, Milford EL, et al. Transplantation in the treatment of renal failure. In: Dietel M, Suttorp N, Zeitz M, et al, eds. Harrisons internal medicine (German edition), vol. 2. Berlin, ABW Wissenschaftsverlag 2005, pp 1789-1797.
23. DaRoza G, Loewen A, Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better. Am J Kidney Dis 2003; 42: 1184.
24. Johnson SE, Rubin L, Romero-Steiner S, et al. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J Infect Dis 1999; 180: 133.
25. Esposito S, Droghetti R, Faelli N, et al. Serum concentrations of pneumococcal anticapsular antibodies in children with pneumonia associated with Streptococcus pneumonia infection. Clin Infect Dis 2003; 37: 1261.
26. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981; 3(suppl): S184.
27. Lindemann M, Virchow S, Ramann F, et al. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett 2001; 495: 82.